Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001209191-23-000300

Options or other derivatives

  • Chief Financial Officer acquired 360,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Fuhrman Alan · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-01-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +32,800 32,800 D
2023-01-01 Grant or award : show line 2 in the form Stock Option (Right to Buy) +328,000 328,000 D
Loading xslF345X03/doc4.xml…